Pulmonary Disease Doctors in Fredericksburg, VA Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Richard A. Fiero, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 521 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-899-1615    Fax: 540-372-3525

Jeffrey R. Rehm, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 521 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-899-1615    Fax: 540-372-3525

Randall B. Currie, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 521 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-899-1615    Fax: 540-372-3525

Rohit Goyal, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 521 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-899-1615

News Archive

Mediacorp names Gamma-Dynacare Medical Laboratories as one of Canada's Top 100 Employers

Gamma-Dynacare Medical Laboratories has been named, for the second consecutive year, as one of Canada's Top 100 Employers and one of the Greater Toronto Area's Top Employers by Mediacorp Canada, Inc.

New, precise definition of boredom based on mental processes

This gives new meaning to the complaint "I'm bored" - literally. Canadian researchers - including a professor from the University of Guelph - have come up with a new, precise definition of boredom based on the mental processes that underlie the condition.

Two surgeons discover previously unknown ligament in the human knee

Two knee surgeons at University Hospitals Leuven have discovered a previously unknown ligament in the human knee. This ligament appears to play an important role in patients with anterior cruciate ligament tears.

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.

Read more Medical News

› Verified 8 days ago